1-3 of 3
Guillermo J. Ruiz-Arguelles, MD, FACP, FRCP, (Glasg)
Close
Sort by
Journal Articles

Is There a Benefit of Adding Rituximab to CHOP in the Overall Survival of Patients with B-Cell Non-Hodgkin′s Lymphoma in a Developing Country ?

Guillermo J. Ruiz-Delgado, MD, David Gomez Almaguer, MD, Luz C. Tarin-Arzaga, MD, Olga Cantú-Rodríguez, MD, Carlos Alarcon-Urdaneta, MD, Uxmal Rodriguez-Morales, MD, Jackeline Calderon-García, MD, Omar Fernandez-Vargas, MD, Maryel Montes-Montiel, MD, Monica Sanchez-Cardenas, MD, Guillermo J. Ruiz-Arguelles, MD, FACP, FRCP (Glasg)
Journal: Blood
Blood (2012) 120 (21): 4892.
https://doi.org/10.1182/blood.V120.21.4892.4892
Published: 2012
Journal Articles

Low Incidence and severity of Graft-Versus-host disease after outpatient allogeneic Peripheral Blood Stem Cell Transplantation employing a Reduced-Intensity Conditioning

Olga Cantú-Rodríguez, MD, Juan A. Flores-Jiménez, MD, Cesar H Gutiérrez-Aguirre, MD, Guillermo J. Ruiz-Arguelles, MD, FACP, FRCP, (Glasg), A López-Otero, MD, Consuelo Mancías-Guerra, MD, Oscar Gonzalez-Llano, MD, Oscar Treviño-Montemayor, Jose C. Jaime-Pérez, MD, Silvia Martínez-Cabriales, David Gomez-Almaguer, MD
Journal: Blood
Blood (2011) 118 (21): 4707.
https://doi.org/10.1182/blood.V118.21.4707.4707
Published: 2011
Journal Articles

The Early Referral for Reduced-Intensity Stem Cell Transplantation in Patients with Ph1 (+) Chronic Myelogenous Leukemia in Chronic Phase in the Imatinib Era: Results of the Latin American Cooperative Oncohematology Group (LACOHG) Prospective, Multicenter Study.

Guillermo J. Ruiz-Arguelles, MD, FACP, FRCP(Glasg), David Gomez-Almaguer, MD, Amelia Morales-Toquero, MD, Cesar H. Gutierrez-Aguirre, Jorge Vela-Ojeda, Miriam A. Garcia-Ruiz-Esparza, MD, Carlos Manzano, MD, Amado Karduss, MD, Abraham Sumoza, MD, Carmino de-Souza, MD, Eliana Miranda, MD, Sergio Giralt, MD
Journal: Blood
Blood (2005) 106 (11): 4838.
https://doi.org/10.1182/blood.V106.11.4838.4838
Published: 2005